Clinical trials: Breast Imaging
Breast Cancer
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
The propose of this prospective study focuses on the role of [18F]FES PET imaging in patients with breast cancer who might receive or are receiving hormone therapy.
- Trial name
- breast (NCT03544762)
- Testing
- 18F-FES PET
- Where
- Taiwan
- Volunteers
- 60 people
- Sponsor
- National Taiwan University Hospital
Breast Cancer
IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO)
Imagio breast imaging system, is an opto-acoustic (OA) imaging system designed to concurrently collect images in conjunction with diagnostic ultrasound ( co-registered OA and B-mode imaging).
- Trial name
- MAESTRO (NCT02364388)
- Testing
- Imagio IUS, Imagio OA/US
- Where
- 5 sites in Netherlands
- Volunteers
- 217 people
- Sponsor
- Seno Medical Instruments Inc.
Breast Cancer
68Ga PET/CT Imaging in Breast Cancer Patients
PSMA is highly expressed on the cell surface of the microvasculature of several solid tumors, including breast cancer. This makes it a potentially imaging target for the detection and grading of breast cancer.
- Trial name
- NCT05622227
- Testing
- Drug: 68Ga-P16-093
- Where
- China
- Volunteers
- 50 people
- Sponsor
- Peking Union Medical College Hospital
Breast Cancer
Tissue Oxygenation Measurements With Modulated Light (S-FLARE)
To perform a pilot study of the S-FLARE imaging system, which uses low levels of safe, invisible, near-infrared light to measure tissue oxygenation during breast reconstructive surgery and to compare S-FLARE measurements to the…
- Trial name
- NCT01116297
- Testing
- Imaging with S-FLARE imaging system
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Beth Israel Deaconess Medical Center
Breast Cancer
Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer
The purpose of this study is to determine if the use of magnetic resonance imaging (MRI) for breast cancer translates into better surgical outcomes.
- Trial name
- BSMART (NCT00948285)
- Testing
- MRI
- Where
- United States
- Volunteers
- 194 people
- Sponsor
- Texas Tech University Health Sciences Center